Takeda M, Sakai K, Terashima H, et al: Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer. Ann Oncol 26 (12): 2477-2482, 2015.
Takeda M, Takahama T, Sakai K, et al: Clinical application of the FoundationOne CDx assay to therapeutic decision-making for patients with advanced solid tumors. Oncologist 26 (4): e588-e596, 2021.
Hayashi H, Kurata T, Takiguchi Y, et al: Randomized phase II trial comparing site-specific treatment based on gene expression profiling with carboplatin and paclitaxel for patients with cancer of unknown primary site. J Clin Oncol 37 (7): 570-579, 2019.
Hayashi H, Takiguchi Y, Minami H, et al: Site-specific and targeted therapy based on molecular profiling by next-generation sequencing for cancer of unknown primary site: a nonrandomized phase 2 clinical trial. JAMA Oncol 6 (12): 1931-1938, 2020.
Haratani K, Hayashi H, Takahama T, et al: Clinical and immune profiling for cancer of unknown primary site. J Immunother Cancer 7 (1): 251, 2019.